Daratumumab (anti-CD38) induces loss of CD38 on red blood cells.
Sullivan HC, Gerner-Smidt C, Nooka AK, Arthur CM, Thompson L, Mener A, Patel SR, Yee M, Fasano RM, Josephson CD, Kaufman RM, Roback JD, Lonial S, Stowell SR.
Sullivan HC, et al. Among authors: mener a.
Blood. 2017 Jun 1;129(22):3033-3037. doi: 10.1182/blood-2016-11-749432. Epub 2017 Apr 3.
Blood. 2017.
PMID: 28373263
Free PMC article.
Clinical Trial.
No abstract available.